Lumibird Medical announced that it has entered into discussions to acquire its long-standing distribution partner, Biz Medic Z SDN BHD, based in Kuala Lumpur, Malaysia. The proposed acquisition paves the way for the creation of Lumibird Medical Southeast Asia, a new regional hub aimed at accelerating growth. According to Lumibird, the move represents a transition from a distributor-led model to a direct subsidiary structure, underscoring the company's commitment to strengthening its presence in the Asia-Pacific region. Southeast Asia has emerged as a critical frontier for eye care, driven by a combination of high clinical demand and rapidly expanding healthcare infrastructure, the company stated. The region faces some of the highest global rates of vision impairment, particularly myopia, alongside a growing prevalence of ophthalmic diseases such as glaucoma and retinal disorders. At the same time, increasing investment in healthcare systems is creating significant opportunities for advanced diagnostic and therapeutic laser technologies. As part of this strategic realignment, Lumibird Medical will centralize its regional operations under the new Southeast Asia hub. This consolidation will involve the closure of its representative office in Thailand and its subsidiary in India, allowing the company to streamline resources and focus on a unified regional approach. Biz Medic Z SDN BHD has been a partner to Lumibird Medical since 2004, helping build the company’s footprint across Southeast Asia. “This acquisition is a pivotal step in our global strategy,” said Jean-Marc Gendre, Director of Lumibird Medical. “Southeast Asia is not just a growing market; it is the most populous region with some of the highest unmet needs in ophthalmology. By establishing this office, we are moving closer to our customers and patients, ensuring that our life-changing technologies are supported by a world-class regional service center.” The transaction is expected to be finalized in the first half of the year. The new Southeast Asia hub will oversee the distribution of Lumibird Medical’s product portfolios, including Quantel Medical, Optotek Medical, and Ellex. This integration is expected to deliver a unified brand presence while addressing the specific regulatory and clinical requirements unique to the Southeast Asian market.